Xtant Medical Holdings (XTNT) Shares Outstanding (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Shares Outstanding data on file, last reported at $140.0 million in Q4 2025.

• Shares Outstanding for Q4 2025 came in at $140.0 million, up 0.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $140.0 million (up 0.71% YoY), and the FY2025 annual result was $140.0 million, up 0.71% from the prior year.
• Shares Outstanding was little changed at $140.0 million in Q4 2025 per XTNT's latest filing, from $140.0 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $140.0 million in Q4 2025 and troughed at $86.7 million in Q1 2021.
• A 5-year average of $115.4 million and a median of $119.3 million in 2023 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding jumped 555.7% in 2021, then advanced 0.7% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $87.1 million in 2021, then grew by 25.04% to $108.9 million in 2022, then advanced by 19.57% to $130.2 million in 2023, then climbed by 6.81% to $139.0 million in 2024, then rose by 0.71% to $140.0 million in 2025.
• Business Quant data shows XTNT's Shares Outstanding at $140.0 million in Q4 2025, $140.0 million in Q3 2025, and $139.3 million in Q2 2025.